Acrivon Therapeutics set to present at 2026 Cantor Global Healthcare Conference
Acrivon Therapeutics says it will present at the 2026 Cantor Global Healthcare Conference, according to the company’s announcement.
WATERTOWN, Mass., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) NASDAQ:ACRV, a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Pre…